Pharmacovigilance and Artificial Intelligence Visionary Award

Vani Pathuri is a dedicated healthcare professional having great experience in the pharmacovigilance domain. Throughout her career, she has been instrumental in managing drug safety operations and ensuring compliance with global safety standards. Vani's expertise lies in overseeing critical aspects of pharmacovigilance, such as Individual Case Safety Reports (ICSRs), and ensuring the successful submission of safety reports to regulatory authorities.

In addition to her practical expertise, Vani has also significantly contributed to the scientific community by writing and publishing papers on the future of artificial intelligence (AI) in pharmacovigilance. Her work explores the transformative potential of AI in streamlining drug safety operations, particularly in ICSR processing and adverse event reporting. By incorporating AI and machine learning into pharmacovigilance systems. She envisions a future where drug safety monitoring becomes more efficient, proactive, and accurate. Her thought leadership in this area positions her as a key figure in the integration of advanced technologies with traditional pharmacovigilance practices.

Vani's work is not only focused on current pharmacovigilance practices but also extends to innovation in handling complex safety concerns, particularly in oncology. By exploring AI’s role in managing the safety of novel cancer therapies, she contributes to shaping the future of personalized and precision medicine. Her research highlights the importance of using advanced data science to predict, monitor, and mitigate adverse events, thereby ensuring safer therapeutic outcomes for patients.

With her deep expertise, innovative thinking, and leadership in the application of AI in pharmacovigilance, Vani Pathuri has established herself as a forward-thinking professional committed to advancing drug safety practices globally. Her projects and contributions continue to inspire progress in the field, making her a valuable asset in the healthcare and pharmaceutical industries.